Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IceCure Medical (ICCM) EBIT Margin (2020 - 2025)

Historic EBIT Margin for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to 451.29%.

  • IceCure Medical's EBIT Margin fell 1972000.0% to 451.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 517.75%, marking a year-over-year increase of 1204200.0%. This contributed to the annual value of 476.94% for FY2024, which is 54400.0% down from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's EBIT Margin is 451.29%, which was down 1972000.0% from 644.76% recorded in Q2 2025.
  • IceCure Medical's EBIT Margin's 5-year high stood at 1260.86% during Q3 2023, with a 5-year trough of 3146.54% in Q4 2022.
  • For the 5-year period, IceCure Medical's EBIT Margin averaged around 235.68%, with its median value being 491.25% (2024).
  • As far as peak fluctuations go, IceCure Medical's EBIT Margin plummeted by -19673500bps in 2022, and later skyrocketed by 34186500bps in 2023.
  • IceCure Medical's EBIT Margin (Quarter) stood at 1179.19% in 2021, then crashed by -167bps to 3146.54% in 2022, then skyrocketed by 109bps to 272.11% in 2023, then skyrocketed by 90bps to 517.14% in 2024, then fell by -13bps to 451.29% in 2025.
  • Its last three reported values are 451.29% in Q3 2025, 644.76% for Q2 2025, and 504.41% during Q1 2025.